Metal chelating agents: solving the mystery of targeting Hepatitis B and C viruses
In this editorial, authors Grigoris Zoidis, Erofili Giannakopoulou and Vasiliki Pardali (National and Kapodistrian University of Athens) discuss their recent work on developing novel metal-chelating agents against HBV and HCV.
Please sign in or register for FREE
Sign in to RxNet
Register to RxNet
RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.